NFE2L2 and non-small cell lung carcinoma: ML385, ARE expression modulator 1 (AEM1) and 4-(2-Cyclohexylethoxy) aniline (IM3829) were identified as synthetic NRF2 inhibitors in NSCLC lines [201,202,203].